Breve intervista durante l’Italian Summit On Precision Medicine con: JAVIER CORTES CASTAN - International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Madrid and Barcelona & Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain

Ieri si è conclusa la quarta edizione dell’Italian Summit On Precision Medicine. A breve saranno disponibili su fondazionefmp.it le registrazioni di tutte le presentazioni e le diapositive di tutti gli interventi. Giuseppe Curigliano & Paolo Marchetti

linkedin.com/posts/gabriell…

Intervista di Irma D’Aria Irma D Aria su Repubblica: Tumori, a che punto siamo con la medicina di precisione: il summit a Roma. Dai Molecular Tumor Board alla profilazione genomica, gli oncologi e la medicina di precisione, risultati e prossime frontiere nella cura dei tumori.

Do more targets allow more cancer treatments, or not? We described the main differences between the oncology models in terms of clinical, technological and organisational aspects for moving across the different regulatory issues and their implications in therapy access.

Vivek Subbiah, MD Nature Medicine Tecan Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Razelle Kurzrock, MD Adam Wahida, MD-PhD Jacob J. Adashek, DO Aakash Desai, MD, MPH Wafik S. El-Deiry, MD, PhD, FACP gilberto lopes Navneet Majhail, MD, MS Erika Hamilton, MD …We need to get clinical trials to where patients are located & not vice versa. … I completely agree with you! For this reason, in a non-profit study such as the Rome trial, we collaborated with 41 centers distributed throughout the Italy, screening 1740 pts in 20 months!

Novel biomarkers to stratify Head and Neck cancer patients treated with pembrolizumab !!@SapienzaRoma Policlinico Umberto I Paolo Marchetti

⭐️Today is International #ClinicalTrials day & we celebrated our clinical trial personnel appreciation yesterday. Thank you to our phase 1 clinical trial team. Your hard work behind the scenes even in the midst of an unprecedented #pandemic enrolling patients on trials has helped

I nostri eventi del 2023. Waiting for 2024... Buon anno a tutti 😀 #medicina #oncologia #oncologiamedica #medicinapersonalizzata

Sono lieto di presentare il IV summit italiano sulla medicina di precisione, che si terrà a Roma. La presenza di relatori di straordinaria competenza nella medicina di precisione fornirà ai partecipanti l’opportunità di un confronto diretto e “personalizzato”!

Impressive response with TDXd also in a real world population!! Paolo Marchetti The Oncologist Matteo Lambertini, MD PhD G Curigliano MD PhD Daniele Marinelli

The OncoAlert 🚨Weekly Round Up Covering April 19-25, 2024 REGISTER AT OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… Discussing ✅ADCs in #LungCancer 🫁& #BreastCancer Out on Annals of Oncology annalsofoncology.org/article/S0923-… ✅TILS in #TNBC jamanetwork.com/journals/jama/… ✅TROPION in

If you care about education, research, and clinical care in Oncology, take a few minutes to vote for Prof. Giuseppe Curigliano as ESMO President. Cast your vote by connecting to the official ESMO website (esmo.org/about-esmo/how…) before noon on June 10th.

Complimenti ed auguri sinceri al Prof. Giuseppe Curigliano, Presidente eletto della Società Europea di Oncologia Medica!

5 minuti per iniziare a parlare di intelligenza artificiale in medicina…

Un grande risultato della ricerca oncologica italiana, reso possibile dall’enorme lavoro dei clinici di tutti i 40 Centri, che, con grande visione ed intuito, hanno percorso questa nuova strada! dailyreporter.esmo.org/esmo-congress-…

A groundbreaking achievement for Italian oncology research, made possible by the tremendous efforts of the clinicians from all 40 Centers, who, with remarkable vision and insight, have boldly paved this new path! dailyreporter.esmo.org/esmo-congress-…